This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (433) Substance Abuse (268) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (89)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43122, first published .
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

Authors of this article:

Hilary Luderer 1 Author Orcid Image ;   Nicole Enman 1 Author Orcid Image ;   Robert Gerwien 1 Author Orcid Image ;   Stephen Braun 1 Author Orcid Image ;   Samantha McStocker 1 Author Orcid Image ;   Xiaorui Xiong 1 Author Orcid Image ;   Carrington Koebele 2 Author Orcid Image ;   Christopher Cannon 2 Author Orcid Image ;   Joseph Glass 3 Author Orcid Image ;   Yuri Maricich 1 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics
Hilary Luderer 1 , PhD ;   Nicole Enman 1 , PhD ;   Robert Gerwien 1 , PhD ;   Stephen Braun 1 , BA ;   Samantha McStocker 1 , BSc ;   Xiaorui Xiong 1 , PhD ;   Carrington Koebele 2 , MD ;   Christopher Cannon 2 , MPH ;   Joseph Glass 3 , PhD ;   Yuri Maricich 1 , MD, MPH

1 Pear Therapeutics (US), Inc , Boston , MA , US

2 Whitman-Walker Institute , Washington , DC , US

3 Kaiser Permanente Washington Health Research Institute , Seattle , WA , US

Corresponding Author: